Biomarin Pharmaceutical Inc (BMRN) — Net Asset Quality Index
Biomarin Pharmaceutical Inc (BMRN) has a Net Asset Quality Index of 80.2% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $7.59 Billion minus total liabilities of $1.51 Billion yields net assets of $6.09 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check Biomarin Pharmaceutical Inc (BMRN) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Biomarin Pharmaceutical Inc Net Asset Quality Index Over Time (1998–2025)
This chart shows how Biomarin Pharmaceutical Inc's Net Asset Quality Index has evolved across 28 annual periods from 1998 to 2025. As of December 2025, the index stands at 80.2%, representing net assets of $6.09 Billion against total assets of $7.59 Billion USD. See working capital position of Biomarin Pharmaceutical Inc to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Biomarin Pharmaceutical Inc (1998–2025)
The table below presents the year-by-year Net Asset Quality Index for Biomarin Pharmaceutical Inc from 1998 to 2025, covering 28 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see BMRN stock market capitalisation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 80.2% | $6.09 Billion | $7.59 Billion | $1.51 Billion | ▼ -0.8 pp |
| 2024 | 81.0% | $5.66 Billion | $6.99 Billion | $1.33 Billion | ▲ +8.6 pp |
| 2023 | 72.4% | $4.95 Billion | $6.84 Billion | $1.89 Billion | ▲ +0.2 pp |
| 2022 | 72.2% | $4.60 Billion | $6.38 Billion | $1.77 Billion | ▲ +1.1 pp |
| 2021 | 71.1% | $4.27 Billion | $6.00 Billion | $1.73 Billion | ▲ +0.9 pp |
| 2020 | 70.2% | $4.11 Billion | $5.85 Billion | $1.74 Billion | ▲ +3.6 pp |
| 2019 | 66.6% | $3.12 Billion | $4.69 Billion | $1.57 Billion | ▼ -0.5 pp |
| 2018 | 67.0% | $2.97 Billion | $4.43 Billion | $1.46 Billion | ▲ +6.4 pp |
| 2017 | 60.6% | $2.81 Billion | $4.63 Billion | $1.82 Billion | ▼ -8.1 pp |
| 2016 | 68.7% | $2.77 Billion | $4.02 Billion | $1.26 Billion | ▲ +4.4 pp |
| 2015 | 64.4% | $2.40 Billion | $3.73 Billion | $1.33 Billion | ▲ +3.0 pp |
| 2014 | 61.4% | $1.53 Billion | $2.49 Billion | $962.56 Million | ▲ +1.6 pp |
| 2013 | 59.8% | $1.34 Billion | $2.24 Billion | $903.02 Million | ▼ -5.0 pp |
| 2012 | 64.8% | $1.02 Billion | $1.57 Billion | $552.58 Million | ▲ +5.6 pp |
| 2011 | 59.2% | $773.05 Million | $1.31 Billion | $532.66 Million | ▲ +2.4 pp |
| 2010 | 56.8% | $717.26 Million | $1.26 Billion | $545.37 Million | ▲ +21.7 pp |
| 2009 | 35.1% | $322.19 Million | $917.16 Million | $594.98 Million | ▲ +4.6 pp |
| 2008 | 30.5% | $276.68 Million | $906.70 Million | $630.02 Million | ▲ +7.5 pp |
| 2007 | 23.0% | $187.73 Million | $815.28 Million | $627.55 Million | ▼ -2.4 pp |
| 2006 | 25.4% | $117.80 Million | $463.44 Million | $345.63 Million | ▲ +65.1 pp |
| 2005 | -39.7% | $-77.46 Million | $195.30 Million | $272.76 Million | ▼ -10.5 pp |
| 2004 | -29.2% | $-67.98 Million | $232.97 Million | $300.94 Million | ▼ -75.2 pp |
| 2003 | 46.0% | $117.85 Million | $256.34 Million | $138.49 Million | ▼ -43.1 pp |
| 2002 | 89.1% | $98.54 Million | $110.62 Million | $12.07 Million | ▼ -3.8 pp |
| 2001 | 92.9% | $159.55 Million | $171.81 Million | $12.26 Million | ▲ +1.9 pp |
| 2000 | 91.0% | $69.99 Million | $76.93 Million | $6.94 Million | ▼ -4.0 pp |
| 1999 | 95.0% | $98.38 Million | $103.55 Million | $5.17 Million | ▲ +1.7 pp |
| 1998 | 93.3% | $29.40 Million | $31.51 Million | $2.11 Million | — |